eli lilly gip/glp-1 Lilly's triple-acting obesity drug hits goal in Phase 3 trial Advancements in Clinical Research and

Patients should ask about the recommended approach for their specific situation, which may include: Following a liquid-only diet for 24 hours before the procedure (in addition to the standard bowel preparation) Whether any medication adjustment is recommended based on individual risk factors What additional precautions the anesthesia team might take Diabetes management considerations are important for patients using GLP-1 agonists for glycemic control

(2) However, a disconcerting unintended consequence of these weight loss meds is that the potential health benefits of diet-induced weight loss are thought to be compromised by the weight-loss-associated loss of lean body mass, which could increase the risk of sarcopenia (low muscle mass and impaired muscle function)

Advise against its use in patients with a hx of HTN- See phentermine consent for additional details/ medication packet regarding phentermine

Pharmacies, hospitals, and some community cooling centers may be willing to store medication temporarily if you explain the situation